D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 16 710 KRW 2.26%
Market Cap: 734.6B KRW
Have any thoughts about
Dongkook Pharmaceutical Co Ltd?
Write Note

Dongkook Pharmaceutical Co Ltd
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dongkook Pharmaceutical Co Ltd
Short-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
D
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Short-Term Investments
â‚©53.9B
CAGR 3-Years
-15%
CAGR 5-Years
-3%
CAGR 10-Years
7%
Yuhan Corp
KRX:000100
Short-Term Investments
â‚©19.1B
CAGR 3-Years
-56%
CAGR 5-Years
-34%
CAGR 10-Years
-21%
SK Biopharmaceuticals Co Ltd
KRX:326030
Short-Term Investments
â‚©1.4B
CAGR 3-Years
-84%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Short-Term Investments
â‚©154B
CAGR 3-Years
290%
CAGR 5-Years
73%
CAGR 10-Years
11%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Short-Term Investments
â‚©16B
CAGR 3-Years
-24%
CAGR 5-Years
-16%
CAGR 10-Years
5%
C
Celltrion Pharm Inc
KOSDAQ:068760
Short-Term Investments
â‚©15B
CAGR 3-Years
29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Dongkook Pharmaceutical Co Ltd
Glance View

Market Cap
734.7B KRW
Industry
Pharmaceuticals

DongKook Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2007-05-29. The firm develops and provides remedies for oral troubles, skin troubles and gynecology diseases, contrast mediums, anesthetics, anticancer medicines and circulatory system agents. The company also provides other pharmaceuticals, such as remedies for arthritis and pancreatitis, antiphlogistic, anodynes, antibiotics and vitamins, as well as raw materials for pharmaceuticals. In addition, it is engaged in the rental business. The firm distributes its products within domestic market and to overseas markets, such as Japan, Germany, India, Brazil and Mexico, among others.

Intrinsic Value
19 388.02 KRW
Undervaluation 14%
Intrinsic Value
Price
D

See Also

What is Dongkook Pharmaceutical Co Ltd's Short-Term Investments?
Short-Term Investments
53.9B KRW

Based on the financial report for Sep 30, 2024, Dongkook Pharmaceutical Co Ltd's Short-Term Investments amounts to 53.9B KRW.

What is Dongkook Pharmaceutical Co Ltd's Short-Term Investments growth rate?
Short-Term Investments CAGR 10Y
7%

Over the last year, the Short-Term Investments growth was 66%. The average annual Short-Term Investments growth rates for Dongkook Pharmaceutical Co Ltd have been -15% over the past three years , -3% over the past five years , and 7% over the past ten years .

Back to Top